Mallinckrodt (NYSE: MNK) today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for PENNSAID® (diclofenac sodium topical solution) 2% w/w. PENNSAID 2% is a topical non-steroidal ...
Signals Potential of Newborn Stem Cells in Regenerative Medicine for Common Disorders Cord Blood Registry® (CBR®), the world's largest and most experienced newborn stem cell company, announces the start of a U.S. Food and Drug ...
Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Supplemental New Drug Application ...
Tags: Iroko Pharmaceuticals, FDA, ZORVOLEX, osteoarthritis pain
Biogen Idec today announced that FAMPYRA(prolonged-release fampridine tablets) has been made available in Ireland for the symptomatic treatment of walking impairment in adults with Multiple Sclerosis (MS). FAMPYRA is a prescription drug and ...
Tags: FAMPYRA, HSE, Biogen Idec, Named Patient Supply
A single question may help doctors determine whether a patient has a drug or alcohol problem and the level of abuse, a new study suggests. Keep it simple is the message from the study of nearly 300 people recruited from the Boston Medical ...
WHITEHOUSE STATION, N.J., Jan. 14 (UPI) -- Merck is voluntarily recalling all lots of Liptruzet, or ezetimibe and atorvastatin, in the United States due to packaging defects, officials say. The drug company is recalling from wholesalers ...
Tags: Liptruzet, wholesaler, USA, FDA
Quick treatment with a new "microparticle" therapy might significantly reduce the damage caused by a heart attack, according to a new study conducted in mice. After a heart attack, much of the damage to the heart muscle is caused by ...
Patients with advanced pancreatic cancer, one of the most deadly malignancies, may live a little longer when treated with two therapeutic vaccines, new research suggests. In a study of 90 patients, this combination approach -- GVAX ...
Tags: a
The Consumer Electronics Association (CEA) announced its sponsorship of an educational program series called the "Mobile Medical Apps (MMA) Roadshow: Managing App Development under FDA Regulation." CEA is joining a consortium of six ...
Tags: Consumer Electronics, Electronics
Caffeine may help long-term memory Whether it's a mug full of coffee, a cup of hot tea, or a can of soft drink, consuming caffeine is the energy boost of choice for millions who want to wake up or stay up. But the popular stimulant could ...
Tags: Caffeine, long-term memory, memory enhancer
Argon Medical Devices, Inc. announced today that the company has received clearance from the US Food and Drug Administration to begin marketing the Option™ELITE retrievable inferior vena cava (IVC) filter with a new over-the-wire ...
The novel avian H7N9 influenza virus has caused more than 130 human infections with 43 deaths in China. New research, conducted under the supervision of Kansas State University's Juergen Richt, is showing promise in helping to fight this ...
Tags: Influenza Virus, H7N9, Health, Medicine
New study identifies drug that could improve treatment of post-traumatic stress disorder Nearly 8 million Americans suffer from posttraumatic stress disorder (PTSD), a condition marked by severe anxiety stemming from a traumatic event ...
Patients with advanced pancreatic cancer, one of the most deadly malignancies, may live a little longer when treated with two therapeutic vaccines, new research suggests. In a study of 90 patients, this combination approach -- GVAX ...
Packaging defects have prompted a recall of a combination cholesterol drug called Liptruzet, produced by Merck & Co., temporarily affecting the entire U.S. stock. Merck said the foil pouches holding Liptruzet pills could allow air and ...
Tags: recall, Liptruzet, Merck, packaging defects